INVO Fertility (IVF)

The company positions this model as a potentially more accessible fertility option for patients and clinics seeking alternatives within the assisted reproductive technology market. Fertility care can be expensive, operationally complex, and concentrated in specialized centers, and INVO Fertility aims to address part of that gap through a combination of device sales and clinic-based services. Its business includes fertility clinic operations, including clinic-related revenue, and a device segment tied to the manufacture and sale of INVOcell.

INVO Fertility also reports a therapeutics segment connected to NTI, an acquired subsidiary. This gives the company activities beyond its original fertility device focus, although its public identity remains closely associated with reproductive medicine and ART access.

The company operates in a market shaped by rising demand for fertility services, later family formation, growing awareness of reproductive health, and continuing innovation in clinical fertility treatment. At the same time, it faces the regulatory, reimbursement, adoption, and capital requirements common to medical device and healthcare services businesses. For investors, IVF provides exposure to a niche fertility-care platform that combines proprietary technology with clinical service operations.